Syngene's FY26 profit drops 20% to ₹316.7 crore, while revenue increases 3% to ₹3,738.7 crore amid client destocking.

Syngene International reported a 20% drop in profit after tax to ₹379.9 crore, despite a 3% increase in revenue from operations to ₹3,738.7 crore, citing client destocking issues.

Rentschler Biopharma, Syngene, and Symeres announce major leadership changes, appointing new CEOs and executives to drive ...

Syngene International Limited has received an order giving effect to a decision passed by the National Faceless Appeal Centre ...

In his resignation letter to the chairman of the company's board, Bains said he is resigning from his position following "our ...

Syngene International, a global contract research, development, and manufacturing organization (CRDMO), today announced that Siddharth Mittal has assumed the role of Managing Director and Chief ...

Peter Bains, Chief Executive Officer of Syngene International Ltd., speaks during a news conference in Mumbai, India, July 16, 2015. REUTERS/Shailesh Andrade MUMBAI (Reuters) - Drugmaker Biocon Ltd ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The life sciences veteran succeeds Peter Bains and says his immediate priorities are strengthening commercial execution, ...

The new proprietary cell line development platform combines a robust cell line, transposon technology with high throughput clone screening and single cell imaging to deliver highly efficient protein ...

Syngene announced the new range of imaging systems will be on Stand 140 at ARABLAB 2017 on March 20th-23rd. Designed for simple set-up and accurate performance, there will be systems on display to ...

Biocon’s innovation focused subsidiary, Syngene International Limited, is expanding in Hyderabad’s Genome Valley by building 16.5 lakh sq ft of cutting edge research laboratories spread over 17.5 ...